Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 22.69% is 963% above its 5-year average of -2.63%, near the high end of its 5-year range (-241.38%–65.55%).
2.68% below its 12-month average of 23.32%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 7.73%.
NET PROFIT MARGIN
22.69%
NET PROFIT MARGIN AVG TTM
23.32%
NET PROFIT MARGIN AVG 3Y
9.52%
NET PROFIT MARGIN AVG 5Y
-2.63%
NET PROFIT MARGIN AVG 10Y
-93.40%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-2.68%
CURRENT VS 3Y AVG
+138.27%
CURRENT VS 5Y AVG
+963.37%
CURRENT VS 10Y AVG
+124.29%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
9.21%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+146.50%
vs the sector median at left
TransMedics Group, Inc.
Market Cap
$2.99B
Net Profit Margin
22.69%
TTM Avg
23.32%
3Y Avg
9.52%
5Y Avg
-2.63%
Market Cap
$1.91B
Net Profit Margin
-14.99%
TTM Avg
-20.12%
3Y Avg
-16.95%
5Y Avg
-10.04%
Market Cap
$1.14B
Net Profit Margin
-7.13%
TTM Avg
-23.45%
3Y Avg
-155.72%
5Y Avg
-114.72%
Market Cap
$4.88B
Net Profit Margin
25.48%
TTM Avg
34.77%
3Y Avg
31.87%
5Y Avg
32.80%
Market Cap
$5.10B
Net Profit Margin
9.22%
TTM Avg
8.68%
3Y Avg
7.83%
5Y Avg
5.80%
Market Cap
$5.59B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-101.30%
5Y Avg
-277.86%
Market Cap
$376.61M
Net Profit Margin
-58.33%
TTM Avg
-67.34%
3Y Avg
-66.78%
5Y Avg
-66.78%
Market Cap
$45.05M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TransMedics Group, Inc. (TMDX) | $2.99B | 22.69% | 23.32% | 9.52% | -2.63% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.91B | -14.99% | -20.12% | -16.95% | -10.04% |
| Teladoc Health, Inc. (TDOC)vs › | $1.14B | -7.13% | -23.45% | -155.72% | -114.72% |
| Doximity, Inc. (DOCS)vs › | $4.88B | 25.48% | 34.77% | 31.87% | 32.80% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.10B | 9.22% | 8.68% | 7.83% | 5.80% |
| NRC Health (NRC)vs › | $463.35M | 4.18% | 12.88% | 16.89% | 20.14% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.59B | 0.00% | 0.00% | -101.30% | -277.86% |
| Shoulder Innovations, Inc. (SI)vs › | $376.61M | -58.33% | -67.34% | -66.78% | -66.78% |
| PDS Biotechnology Corporation (PDSB)vs › | $45.05M | 0.00% | 0.00% | 0.00% | 0.00% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.24B | -5.51% | 7.00% | -0.29% | -8.82% |
Operating Margin
12.2%
Net Profit Margin
22.7%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 7.73% |
| 2026-03-31 | 4.21% |
| 2025-12-31 | 65.55% |
| 2025-09-30 | 16.91% |
| 2025-06-30 | 22.18% |
| 2025-03-31 | 17.89% |
| 2024-12-31 | 5.64% |
| 2024-09-30 | 3.88% |
| 2024-06-30 | 10.67% |
| 2024-03-31 | 12.59% |
| 2023-12-31 | 4.97% |
| 2023-09-30 | -38.27% |
| 2023-06-30 | -1.91% |
| 2023-03-31 | -6.34% |
| 2022-12-31 | -21.42% |
| 2022-09-30 | -28.91% |
| 2022-06-30 | -56.15% |
| 2022-03-31 | -66.51% |
| 2021-12-31 | -131.03% |
| 2021-09-30 | -241.38% |
| 2021-06-30 | -130.56% |
| 2021-03-31 | -112.25% |
| 2020-12-31 | -82.75% |
| 2020-09-30 | -71.75% |
| 2020-06-30 | -250.58% |
| 2020-03-31 | -117.56% |
| 2019-12-31 | -151.51% |
| 2019-09-28 | -114.92% |
| 2019-06-29 | -162.28% |
| 2019-03-30 | -147.46% |
| 2018-12-31 | -215.43% |
| 2018-09-30 | -126.39% |
| 2018-06-30 | -209.78% |
| 2018-03-31 | -194.56% |
| 2017-12-30 | -220.70% |
| 2017-09-30 | -257.42% |
| 2017-07-01 | -257.35% |
| 2017-04-01 | -306.28% |
